α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
2020 · Nature Communications · 378 citations
https://doi.org/10.1038/s41467-020-15626-w
D
David G. Standaert
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
447
Papers
32.3K
Citations
98
h-index
258
i10-index
David G. Standaert is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & Neurological disorders and treatments & Neuroscience and Neuropharmacology Research. The author has an h-index of 98, co-authored 380 publications.
ORCID: 0000-0003-2921-8348Papers by this author
worksCD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
2012 · Journal of Neuroimmune Pharmacology · 316 citations
https://doi.org/10.1007/s11481-012-9402-z
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
2022 · Nature Communications · 305 citations
https://doi.org/10.1038/s41467-022-34667-x
Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
2008 · Molecular Brain · 251 citations
https://doi.org/10.1186/1756-6606-1-17
Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease
2017 · Experimental Neurology · 220 citations
https://doi.org/10.1016/j.expneurol.2017.11.010
Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease
2010 · Cell Death and Disease · 140 citations
https://doi.org/10.1038/cddis.2009.4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat